Cargando…
SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience
BACKGROUND: The COVID-19 pandemic has significantly impacted the management of solid organ transplant recipients and on clinical evolution in post-transplantation. Little is known on the impact of SARS-CoV-2 infection in these patients. The severity and lethality of this disease in solid organ trans...
Autores principales: | Pinchera, Biagio, Spirito, Lorenzo, Ferreri, Lucia, Rocca, Roberto La, Celentano, Giuseppe, Buonomo, Antonio Riccardo, Foggia, Maria, Scotto, Riccardo, Federico, Stefano, Gentile, Ivan, Carrano, Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995796/ https://www.ncbi.nlm.nih.gov/pubmed/35419375 http://dx.doi.org/10.3389/fmed.2022.864865 |
Ejemplares similares
-
mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study
por: Pinchera, Biagio, et al.
Publicado: (2022) -
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients
por: Biagio, Pinchera, et al.
Publicado: (2022) -
Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A Single Centre, Real-Life Study
por: Scotto, Riccardo, et al.
Publicado: (2023) -
Update on the Management of Surgical Site Infections
por: Pinchera, Biagio, et al.
Publicado: (2022) -
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study
por: Gentile, Ivan, et al.
Publicado: (2022)